Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05723523 · ClinicalTrials.gov registry record · NA
A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 3,230
- Enrollment target
NCT05723523 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 3,230 participants.
The verdict
NCT05723523, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,230 participants
- Enrollment target
Study Summary
Most experts advocate for early detection of cognitive impairment (CI) so that patients and caregivers can be prepared for making difficult decisions and to improve quality of life, but studies show that screening alone isn't sufficient to change clinician actions related to early detection. Using predictive modelling developed with machine learning methods and sophisticated clinical decision support (CDS) tools, it is possible to identify patients at elevated risk for CI and make it much easier for primary care to engage and support patients and caregivers in meaningful care planning. The goal of this study is to implement and evaluate a low-cost, highly scalable CI-CDS system integrated within the electronic health record that has high potential to improve early CI detection and care and translate massive public and private sector investments in health informatics into tangible health benefits for large numbers of people.
Interventions
- OTHER CI-CDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,230 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05723523
The ClinicalTrials.gov registry entry for NCT05723523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CI-CDS is the first listed.
NCT05723523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05723523 about?
NCT05723523 is a clinical study titled "A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment". Most experts advocate for early detection of cognitive impairment (CI) so that patients and caregivers can be prepared for making difficult decisions and to improve quality of life, but studies show that screening alone isn't sufficient to change clinician actions related to early detection. Using p...
What is the current status of trial NCT05723523?
This trial is currently completed. It is a NA study. The enrollment target is 3,230 participants. The study started on 2023-08-23. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05723523?
The interventions under investigation include: CI-CDS (OTHER).
Who is sponsoring clinical trial NCT05723523?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.